bpc-157 human clinical trials randomized for ACL recovery: hype vs. science | Adam C. Cady MHS, ATC, CSCS, PA-C posted on the topic Stable Gastric Pentadecapeptide BPC 157
Description
Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms
2008;1(40):p
doi: 10.2174/138955711795305335 152
BPC 157 therapy was assessed in counteracting rapid clot formation in the portal vein, superior mesenteric vein, splenic vein, inferior vena cava, hepatic artery, and coronary artery, as well as peaked P waves, significant ST-elevation, tachycardia, gross organ lesions, and liver and spleen weight increases
&srotate=0)
